Phen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Founded in 2011, Phen’X Technologies is specialized in medical subcontracting of implants and instruments for dental, maxillofacial and orthopedic applications. With two production sites in France and Portugal, the company manufactures a wide range of components to support surgeons in dental implantology, facial remodeling and orthopedics. The firm also assists its clients in industrialization projects, from the realization of 3D plans and prototypes to the machining of mass-produced parts.
Ciclad is a long-standing, independent private equity investor supporting the growth of small and mid-sized companies in France and abroad. Established in 1988, Ciclad has invested alongside more than 180 executives and management teams. It is involved in buy-outs and capital strengthening, particularly complex transactions such as spin-offs and carveouts, in contexts of strong development – organic growth and build-up – and turnarounds.
Oaklins’ team in France acted as the exclusive financial advisor to the shareholders of Phen’X Technologies in this LBO.
Contacter l'équipe de la transaction
Transactions connexes
Pharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
En apprendre plusHe-Man Dual Controls has been acquired by Lagercrantz UK Limited
Lagercrantz UK Limited has acquired 100% of the shares in HM Holding Limited (He-Man Dual Controls), a leader in supplemental control systems for vehicles.
En apprendre plusAll Glass & Windows has been recapitalized by Cross Rapids Capital
Prospect Partners has sold All Glass & Windows (AGW) to Cross Rapids Capital.
En apprendre plus